The use of the fecal occult blood test for colorectal cancer screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose.
Dr Douglas Robertson and colleagues from Vermont, USA summarized current evidence for fecal immunochemical test in colorectal neoplasia detection and the comparative effectiveness of fecal immunochemical test relative to other commonly used colorectal cancer screening modalities.
|The fecal immunochemical test is increasingly used relative to conventional fecal occult blood test|
|American Journal of Gastroenterology|
The fecal immunochemical test, as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional fecal occult blood test, and is increasingly used relative to that test.
Dr Robertson's team concludes, "Based on evidence, guidance statements on fecal immunochemical test application were developed, and quality metrics for program implementation proposed."